Consecutive Controlled Case Series on Effectiveness of Opipramol in Severe Sleep Bruxism Management—Preliminary Study on New Therapeutic Path

Background: Sleep bruxism (SB) management aims to reduce the number and magnitude of bruxism episodes per hour of a patient’s sleep and, therefore, reduce the potentially negative clinical consequences. Opipramol belongs to the group of tricyclic antidepressants (TCAs) and is considered as an atypic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieckiewicz, Mieszko, Martynowicz, Helena, Wieczorek, Tomasz, Wojakowska, Anna, Sluzalec-Wieckiewicz, Katarzyna, Gac, Pawel, Poreba, Rafal, Mazur, Grzegorz, Winocur, Efraim, Smardz, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911172/
https://www.ncbi.nlm.nih.gov/pubmed/33499332
http://dx.doi.org/10.3390/brainsci11020146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911172/
https://www.ncbi.nlm.nih.gov/pubmed/33499332
http://dx.doi.org/10.3390/brainsci11020146

Ejemplares similares